Latest News Senhwa Biosciences Shines at G4thering 2025, Reinforcing Global Leadership and Driving International Cooperation Jun 04 2025 Latest News Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma. Apr 02 2025 Latest News Senhwa Biosciences Recognized by European Media as One of Taiwan’s Most Noteworthy Biotech Companies in 2025 Mar 07 2025 Media Coverage Seven biotech companies keeping Taiwan dynamic in 2025 Mar 07 2025 Media Coverage Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors Sep 30 2024 Media Coverage Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI Sep 18 2024 Publications Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer Aug 09 2024 Publications CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci. Jul 08 2024 Publications Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options Sep 22 2023